Terms: = Brain cancer AND ATRX, P46100, ZNF-HX, XNP, XH2, SHS, SFM1, RAD54, MRXHF1, MGC2094, ATR2, 546
507 results:
1. A multi-omics analysis-based model to predict the prognosis of low-grade gliomas.
Du Z; Jiang Y; Yang Y; Kang X; Yan J; Liu B; Yang M
Sci Rep; 2024 Apr; 14(1):9427. PubMed ID: 38658591
[TBL] [Abstract] [Full Text] [Related]
2. STING is significantly increased in high-grade glioma with high risk of recurrence.
Zhong M; Long M; Han C; Ji S; Yang Q
Oncoimmunology; 2024; 13(1):2327682. PubMed ID: 38516268
[TBL] [Abstract] [Full Text] [Related]
3. Intratumoral histological and molecular heterogeneity in an adult diffuse glioma.
Yogaretnam T; Heffernan J; Leung R; Heeney C; Walsh A; Looby S; Caird J; Brett FM
Clin Neuropathol; 2024; 43(2):60-64. PubMed ID: 38495012
[TBL] [Abstract] [Full Text] [Related]
4. High-Grade Astrocytoma with Piloid Features: A Dual Institutional Review of Imaging Findings of a Novel Entity.
Soni N; Agarwal A; Ajmera P; Mehta P; Gupta V; Vibhute M; Gubbiotti M; Mark IT; Messina SA; Mohan S; Bathla G
AJNR Am J Neuroradiol; 2024 Apr; 45(4):468-474. PubMed ID: 38485198
[TBL] [Abstract] [Full Text] [Related]
5. Intracranial dural arteriovenous fistulas: association with cerebral venous thrombosis, baseline aggressiveness, and clinical outcomes. A retrospective multicenter study on 263 consecutive patients and literature review.
Cohen C; Lenck S; Talbi A; Ifergan H; Premat K; Boulouis G; Janot K; Boch AL; Magni C; Herbreteau D; Sourour N; Shotar E; Barrot V; Clarençon F
Neurosurg Focus; 2024 Mar; 56(3):E9. PubMed ID: 38428003
[TBL] [Abstract] [Full Text] [Related]
6. Patterns of T2-FLAIR discordance across a cohort of adult-type diffuse gliomas and deviations from the classic T2-FLAIR mismatch sign.
Malik P; Soliman R; Chen YA; Munoz DG; Das S; Bharatha A; Mathur S
Neuroradiology; 2024 Apr; 66(4):521-530. PubMed ID: 38347151
[TBL] [Abstract] [Full Text] [Related]
7. Molecular Determinants of Neurocognitive Deficits in Glioma: Based on 2021 WHO Classification.
Zhang K; Yang T; Xia Y; Guo X; Chen W; Wang L; Li J; Wu J; Xiao Z; Zhang X; Jiang W; Xu D; Guo S; Wang Y; Shi Y; Liu D; Li Y; Wang Y; Xing H; Liang T; Niu P; Wang H; Liu Q; Jin S; Qu T; Li H; Zhang Y; Ma W; Wang Y
J Mol Neurosci; 2024 Feb; 74(1):17. PubMed ID: 38315329
[TBL] [Abstract] [Full Text] [Related]
8. IDH1 mutation predicts seizure occurrence and prognosis in lower-grade glioma adults.
Tang T; Wang Y; Dai Y; Liu Q; Fan X; Cheng Y; Tang J; Xiao X; Shan Y; Wei P; Zhao G
Pathol Res Pract; 2024 Feb; 254():155165. PubMed ID: 38286053
[TBL] [Abstract] [Full Text] [Related]
9. Expression of molecular markers and synergistic anticancer effects of chemotherapy with antimicrobial peptides on glioblastoma cells.
Chernov AN; Kim AV; Skliar SS; Fedorov EV; Tsapieva AN; Filatenkova TA; Chutko AL; Matsko MV; Galimova ES; Shamova OV
Cancer Chemother Pharmacol; 2024 May; 93(5):455-469. PubMed ID: 38280033
[TBL] [Abstract] [Full Text] [Related]
10. Interplay between atrx and IDH1 mutations governs innate immune responses in diffuse gliomas.
Hariharan S; Whitfield BT; Pirozzi CJ; Waitkus MS; Brown MC; Bowie ML; Irvin DM; Roso K; Fuller R; Hostettler J; Dharmaiah S; Gibson EA; Briley A; Mangoli A; Fraley C; Shobande M; Stevenson K; Zhang G; Malgulwar PB; Roberts H; Roskoski M; Spasojevic I; Keir ST; He Y; Castro MG; Huse JT; Ashley DM
Nat Commun; 2024 Jan; 15(1):730. PubMed ID: 38272925
[TBL] [Abstract] [Full Text] [Related]
11. Analysis of Histomorphologic/Molecular Association and Immune Checkpoint Regulators in Epithelioid Glioblastoma and Pleomorphic Xanthoastrocytoma: Are These Tumors Potential Candidates for Immune Checkpoint Blockade?
Mahajan S; Singh J; Dandapath I; Jha P; Chaturvedi S; Ahuja A; Bhardwaj M; Saran R; Garg A; Sharma MC; Manjunath N; Suri A; Sarkar C; Suri V
Appl Immunohistochem Mol Morphol; 2024 Feb; 32(2):84-95. PubMed ID: 38158760
[TBL] [Abstract] [Full Text] [Related]
12. MRI characteristics of H3 G34-mutant diffuse hemispheric gliomas and possible differentiation from IDH-wild-type glioblastomas in adolescents and young adults.
Shao H; Gong J; Su X; Chen N; Li S; Yang X; Zhang S; Huang Z; Hu W; Gong Q; Liu Y; Yue Q
J Neurosurg Pediatr; 2024 Mar; 33(3):236-244. PubMed ID: 38157540
[TBL] [Abstract] [Full Text] [Related]
13. Multiparametric MRI and T2/FLAIR mismatch complements the World Health Organization 2021 classification for the diagnosis of IDH-mutant 1p/19q non-co-deleted/atrx-mutant astrocytoma.
Sawlani V; Jen JP; Patel M; Jain M; Haq H; Ughratdar I; Wykes V; Nagaraju S; Watts C; Pohl U
Clin Radiol; 2024 Mar; 79(3):197-204. PubMed ID: 38101998
[TBL] [Abstract] [Full Text] [Related]
14. "De novo replication repair deficient glioblastoma, IDH-wildtype" is a distinct glioblastoma subtype in adults that may benefit from immune checkpoint blockade.
Hadad S; Gupta R; Oberheim Bush NA; Taylor JW; Villanueva-Meyer JE; Young JS; Wu J; Ravindranathan A; Zhang Y; Warrier G; McCoy L; Shai A; Pekmezci M; Perry A; Bollen AW; Phillips JJ; Braunstein SE; Raleigh DR; Theodosopoulos P; Aghi MK; Chang EF; Hervey-Jumper SL; Costello JF; de Groot J; Butowski NA; Clarke JL; Chang SM; Berger MS; Molinaro AM; Solomon DA
Acta Neuropathol; 2023 Dec; 147(1):3. PubMed ID: 38079020
[TBL] [Abstract] [Full Text] [Related]
15. Pediatric glioma histone H3.3 K27M/G34R mutations drive abnormalities in PML nuclear bodies.
Voon HPJ; Hii L; Garvie A; Udugama M; Krug B; Russo C; Chüeh AC; Daly RJ; Morey A; Bell TDM; Turner SJ; Rosenbluh J; Daniel P; Firestein R; Mann JR; Collas P; Jabado N; Wong LH
Genome Biol; 2023 Dec; 24(1):284. PubMed ID: 38066546
[TBL] [Abstract] [Full Text] [Related]
16. Protein-centric omics analysis reveals circulating complements linked to non-viral liver diseases as potential therapeutic targets.
Shi Y; Dong H; Sun S; Wu X; Fang J; Zhao J; Han J; Li Z; Wu H; Liu L; Wu W; Tian Y; Yuan G; Fan X; Xu C
Clin Mol Hepatol; 2024 Jan; 30(1):80-97. PubMed ID: 38061333
[TBL] [Abstract] [Full Text] [Related]
17. General Clinico-Pathological Characteristics in Glioblastomas in Correlation with p53 and Ki67.
Sipos TC; Kövecsi A; Ovidiu-Ioan Ș; Zsuzsánna P
Medicina (Kaunas); 2023 Oct; 59(11):. PubMed ID: 38003967
[No Abstract] [Full Text] [Related]
18. Novel, clinically relevant genomic patterns identified by comprehensive genomic profiling in atrx-deficient IDH-wildtype adult high-grade gliomas.
Bedics G; Szőke P; Bátai B; Nagy T; Papp G; Kránitz N; Rajnai H; Reiniger L; Bödör C; Scheich B
Sci Rep; 2023 Oct; 13(1):18436. PubMed ID: 37891325
[TBL] [Abstract] [Full Text] [Related]
19. Radiotherapy for brain Metastases Near the End of Life: Characterizing Patients and Tumor Features.
Silva SB; Barreto RB; de Oliveira FCG; Martin GSD; Takiguchi OMY; Chirichela IA; Miranda MHF; Bodnar D; Alves Reis LA; Pereira GCB; Miranda IL; Pereira BR; Arruda GV; Peria FM
JCO Glob Oncol; 2023 Sep; 9():e2300143. PubMed ID: 37883725
[TBL] [Abstract] [Full Text] [Related]
20. An immune signature to predict the prognosis of
Cao W; Sun P; Luo S; Zeng Z; Xiao C; Yu W; Lei S
Aging (Albany NY); 2023 Oct; 15(19):10453-10472. PubMed ID: 37812190
[TBL] [Abstract] [Full Text] [Related]
[Next]
